Net profit up to September stood at 1.48 M € compared to -0.23 M € in previous year
Operational optimization led to a further recovery of Natraceutical’s net result
- Natraceutical closed September with a consolidated turnover of 25.10 million euros, compared to 32.42 million euros in the same period last year.
- The operational improvement in Forté Pharma, along with the reduction of costs in the corporate structure and the result from Natraceutical Industrial (holding company of former Ingredients Division) by marginal activities, partially offset the effects of the decline in sales at the operating income level.
- This, together with the contribution of Naturex to the result, a 35.5% decrease in financial expenses and financial income by the reduction of the shareholding in Naturex enabled Natraceutical to close the third quarter of the year with an accumulated net profit of 1.48 million euros compared to -0.23 million in the same period last year.